Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples